Active vaccine

Aus coViki
Wechseln zu: Navigation, Suche
GET 2020. Assessment of risk of disease enhancement with COVID-19 vaccines. Extract
Consensus summary report for CEPI/BC March 12-13, 2020 meeting:
GET 2020. Towards effective COVID19 vaccines: Updates, perspectives and challenges (Review) Extract
  • GET 2020. A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2 Extract
  • GET 2020. Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19 Extract
  • GET 2020. Computers and viral diseases Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus Extract
  • GET ä. The SARS-CoV-2 Vaccine Pipeline: an Overview Extract
  • GET 2020. Timely development of vaccines against SARS-CoV-2 Extract
  • GET 2020. In silico identification of vaccine targets for 2019-nCoV Extract
  • GET 2020. Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses Extract
  • GET 2020. Can an effective SARS-CoV-2 vaccine be developed for the older population? Extract
  • GET ä. SARS-CoV-2 Vaccines: Status Report Extract
  • GET 2020. Coronavirus Vaccines: Light at the End of the Tunnel Extract
  • GET 2020. Epitope based vaccine prediction for SARS-COV-2 by deploying immuno-informatics approach Extract
  • GET 2020. Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico study Extract
  • GET ä. Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2 Extract
  • GET ä. In the search of potential epitopes for Wuhan seafood market pneumonia virus using high order nullomers Extract
  • GET ä. Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure Extract
  • Oxford vaccine failed in monkeys
  • GET ä. COVID-19: Is Everything Appropriate to Create an Effective Vaccine? Extract
  • GET ä. Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains Extract
  • GET 2020. Immunoinformatics?aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019?nCoV Extract
  • GET ä. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development Extract
  • Nature: The COVID-19 vaccine development landscape
  • GET 2020. What policy makers need to know about COVID-19 protective immunity Extract
  • GET 2020. Identification of potential cross-protective epitope between a new type of coronavirus (2019-nCoV) and severe acute respiratory syndrome virus Extract
  • GET 2020. Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection Extract
  • GET ä. Inactivated vaccine for SARS-CoV-2 Extract
  • GET 2020. Novel decoy cellular vaccine strategy utilizing transgenic antigen-expressing cells as immune presenter and adjuvant in vaccine prototype against SARS-CoV-2 virus Extract
  • GET ä. Cancer therapy tool informs COVID-19 vaccines Extract
  • GET 2020. The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines Extract
  • GET 2020. News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine Extract
  • GET 2020. Strategies for vaccine development of COVID-19 Extract
  • GET ä. Progress and Concept for COVID?19 Vaccine Development Extract
  • GET 2020. What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19? Extract
  • GET 2020. Progress and Prospects on Vaccine Development against SARS-CoV-2 Extract
  • GET 2020. Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies Extract
  • GET ä. Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses Extract
  • GET ä. Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses: (Trends in Immunology 41, 355?359; 2020) Extract
  • GET 2020. Covid-19: What do we know so far about a vaccine? Extract
  • GET 2020. Developing a vaccine for covid-19 Extract
  • GET 2020. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics Extract
  • GET 2020. Potential of live pathogen vaccines for defeating the COVID-19 pandemic: history and mechanism Extract
  • GET 2020. Defining Protective Epitopes for COVID-19 Vaccination Models Extract
  • GET ä. Deconvoluting Lipid Nanoparticle Structure for Messenger RNA Delivery Extract
  • GET 2020. An Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development Extract
  • GET ä. Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2 Extract
  • GET 2020. Scores of coronavirus vaccines are in competition - how will scientists choose the best? Extract
  • GET 2020. Developing Covid-19 Vaccines at Pandemic Speed Extract
  • GET 2020. Progress and challenge of vaccine development against 2019 novel coronavirus (2019-nCoV) Extract
  • GET 2020. Possible treatment of Covid-19 with a therapeutic vaccine Extract
  • GET 2020. Possible method for the production of a Covid-19 vaccine Extract
  • GET 2020. Vaccins anti-covid-19 : les recherches de johnson & johnson, sanofi et pasteur Extract
  • GET 2020. COVID-19 shot protects monkeys Extract
  • GET 2020. On the front lines of the coronavirus-vaccine battle Extract
  • GET 2020. The race for coronavirus vaccines: a graphical guide Extract
  • GET ä. Development of an inactivated vaccine candidate for SARS-CoV-2 Extract
  • GET 2020. COVID-19 vaccines: breaking record times to first-in-human trials Extract
  • GET 2020. Biomimetic nanoparticles as universal influenza vaccine Extract
GET 2020. (Deutsche Szene) Schutz vor und Hilfe bei Covid19 Infektionen Extract
GET 2018. Herd immunity: hyperimmune globulins for the 21st century Extract
megapool for the top useful human mab
  • GET 2019. (+)First clinical trial of a MERS coronavirus DNA vaccine Extract
  • GET 2006. (+)Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus Extract
  • GET 2020. The expanding role of mass spectrometry in the field of vaccine development Extract
  • GET ä. (+)Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial Extract
  • GET 2020. (+)Gold nanoparticle?adjuvanted S protein induces a strong antigen?specific IgG response against severe acute respiratory syndrome?related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs Extract
  • GET 2020. COVID-19 vaccines: breaking record times to first-in-human trials Extract
  • GET 2020. Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2 Extract
  • GET 2020. An effective CTL peptide vaccine for Ebola Zaire Based on Survivors? CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design Extract
  • GET 2020. Enabling emergency mass vaccination: Innovations in manufacturing and administration during a pandemic Extract
  • GET 2020. Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients. Extract
  • GET 2020. Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV. Extract
  • GET 2020. Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2. Extract
  • GET 2020. A Novel Vaccine Employing Non-Replicating Rabies Virus Expressing Chimeric SARS-CoV-2 Spike Protein Domains: Functional Inhibition of Viral/Nicotinic Acetylcholine Receptor Complexes. Extract
  • GET 2020. SARS-CoV-2 (COVID-19) Vaccine Development and Production: An Ethical Way Forward. Extract
  • GET 2020. COVIDep: a web-based platform for real-time reporting of vaccine target recommendations for SARS-CoV-2. Extract
  • GET 2020. On setting expectations for a SARS-CoV-2 Vaccine. Extract
  • GET 2020. The Importance of Advancing SARS-CoV-2 Vaccines in Children. Extract



  • GET 2020. A strategic approach to COVID-19 vaccine R&D. Extract
  • GET 2020. Rapid COVID-19 vaccine development. Extract


  • GET 2020. The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients. Extract
  • GET ä. Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV Extract
  • GET 2020. Development of SARS-CoV-2 vaccines: should we focus on mucosal immunity? Extract
  • GET 2020. SARS-CoV-2, from its current highly contagious spreading toward the global development of an effective and safe vaccine: challenges and uncertainties. Extract
  • GET 2020. Design of multi-epitope vaccine candidate against SARS-CoV-2: a in-silico study. Extract
  • GET 2020. COVID-19 vaccines: knowing the unknown. Extract
  • GET 2020. The early landscape of COVID-19 vaccine development in the UK and rest of the world. Extract
  • GET 2020. Why Challenge Trials of SARS-CoV-2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events. Extract
  • GET 2020. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines: Setting Expectations Appropriately. Extract
  • GET 2020. Coronavirus vaccines: five key questions as trials begin. Extract
  • GET 2020. Questions remain following first COVID-19 vaccine results. Extract
  • GET 2020. If a coronavirus vaccine arrives, can the world make enough? Extract
  • GET 2020. Understanding the B and T cell epitopes of spike protein of severe acute respiratory syndrome coronavirus-2: A computational way to predict the immunogens. Extract
  • GET 2020. Advances in skin science enable the development of a COVID-19 Vaccine. Extract
  • GET 2020. Protective Adaptive Immunity Against Severe Acute Respiratory Syndrome Coronaviruses 2 (SARS-CoV-2) and Implications for Vaccines. Extract
  • GET 2020. COVID-19 vaccine development pipeline gears up. Extract
  • GET 2020. COVID-19 vaccine development and the way forward. Extract
  • GET ä. (+)Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines? Extract
  • GET 2020. (+)Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development. Extract
  • GET 2020. Influence of immune aging on vaccine responses Extract
  • GET 2020. In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction. Extract
  • GET 2020. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2). Extract
  • GET 2020. 2019-nCoV - Towards a 4th generation vaccine. Extract
  • GET 2020. A vaccine is not too far for COVID-19. Extract
  • GET 2020. Balancing Expediency and Scientific Rigor in SARS-CoV-2 Vaccine Development. Extract
  • GET 2020. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach. Extract
  • GET 2020. The quest to find an effective vaccine for COVID-19. Extract
  • GET 2020. Race for a COVID-19 vaccine. Extract
  • GET 2020. COVID-19: The race for a vaccine. Extract
  • GET 2020. COVID-19 vaccines start moving into advanced trials. Extract
  • GET 2020. Design of a Novel Multi Epitope-Based Vaccine for Pandemic Coronavirus Disease (COVID-19) by Vaccinomics and Probable Prevention Strategy against Avenging Zoonotics. Extract
  • GET 2020. High throughput and comprehensive approach to develop multiepitope vaccine against minacious COVID-19. Extract
  • GET 2020. SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines. Extract
  • GET 2020. U.S. 'Warp Speed' vaccine effort comes out of the shadows. Extract
  • GET 2020. Vaccination strategies to combat novel corona virus SARS-CoV-2. Extract
  • GET 2020. Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach. Extract
  • GET 2020. Death threats after a trial on chloroquine for COVID-19. Extract
  • GET 2020. Caution and clarity required in the use of chloroquine for COVID-19. Extract
  • GET 2020. The starting line for COVID-19 vaccine development. Extract
  • GET 2020. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Extract
  • GET 2020. From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development. Extract
  • GET 2020. The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2. Extract
  • GET 2020. COVID-19 vaccines: neutralizing antibodies and the alum advantage. Extract
  • GET 2020. Immunogenicity of a DNA vaccine candidate for COVID-19. Extract

}}

  • GET 2020. Universal coronavirus vaccines: the time to start is now. Extract
  • GET 2020. Certainty of success: three critical parameters in coronavirus vaccine development. Extract
  • GET 2020. The vaccine journey for COVID-19: a comprehensive systematic review of current clinical trials in humans. Extract
GET 2020. mRNA Vaccines: Possible Tools to Combat SARS-CoV-2. Extract
  • GET 2020. Tortoises, hares, and vaccines: A cautionary note for SARS-CoV-2 vaccine development. Extract
  • GET 2020. A Veterinary Vaccine Development Process Map to assist in the development of new vaccines. Extract
  • GET 2020. Immunoinformatics and Structural Analysis for Identification of Immunodominant Epitopes in SARS-CoV-2 as Potential Vaccine Targets. Extract
  • GET 2020. Prospects of Replication-Deficient Adenovirus Based Vaccine Development against SARS-CoV-2. Extract
  • GET 2020. Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits. Extract
  • GET 2020. DNA vaccine protection against SARS-CoV-2 in rhesus macaques. Extract
GET 2020. Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses. Extract
  • GET 2020. Calling for an exponential escalation scheme in vaccine development for COVID-19. Extract
  • GET 2020. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Extract
  • GET 2020. Why do SARS-COV vaccines not exist? The pharma scientific intelligence and business model must be revisited! Extract
  • GET 2020. Vaccine development and therapeutic design for 2019-nCoV/SARS-CoV-2: Challenges and chances. Extract
  • GET 2020. Anticipating SARS-CoV-2 Vaccine Testing, Licensure, and Recommendations for Use. Extract
  • GET 2020. SARS-CoV-2 vaccines: 'Warp Speed' needs mind melds not warped minds. Extract
  • GET 2020. Preclinical data from SARS-CoV-2 mRNA vaccine. Extract
  • GET 2020. Hydroxychloroquine use in COVID-19: what is the basis for baseline tests? Extract
  • GET 2020. Optimizing safety surveillance for COVID-19 vaccines. Extract
  • GET 2020. Emerging vaccine delivery systems for COVID-19: Functionalised silica nanoparticles offer a potentially safe and effective alternative delivery system for DNA/RNA vaccines and may be useful in the hunt for a COVID-19 vaccine. Extract
  • GET 2020. Is the production of a Covid-19 vaccine using transformed Pasteurella plausible? Extract
  • GET 2020. Design of a Multiepitope-Based Peptide Vaccine against the E Protein of Human COVID-19: An Immunoinformatics Approach. Extract
  • GET 2020. How to expedite early-phase SARS-CoV-2 vaccine trials in pandemic setting-A practical perspective. Extract
GET 2020. Coronaviruses' sugar shields as vaccine candidates. Extract
  • GET 2020. The Challenges of Vaccine Development against a New Virus during a Pandemic. Extract
  • GET 2020. Rational Vaccine Design in the Time of COVID-19. Extract
GET 2020. Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach. Extract
  • GET 2020. Acute Respiratory Failure Secondary to COVID-19 Viral Pneumonia Managed With Hydroxychloroquine/Azithromycin Treatment. Extract
  • GET 2020. The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development. Extract
  • GET 2020. "Es wird mehrere Pandemie-Impfstoffe geben" : SARS-CoV-2 / COVID-19. Extract
  • GET 2020. Vielversprechender Impfstoffkandidat gegen COVID-19 identifiziert. Extract
  • GET 2020. The journey of remdesivir: from Ebola to COVID-19. Extract
  • GET 2020. [Progress and analysis on the development of 2019-nCoV vaccine]. Extract
GET 2020. Accelerating Development of SARS-CoV-2 Vaccines - The Role for Controlled Human Infection Models. Extract
  • GET 2020. Coronavirus vaccine trials have delivered their first results - but their promise is still unclear. Extract
  • GET 2020. Latin American scientists join the coronavirus vaccine race: 'No one's coming to rescue us'. Extract
  • GET 2020. Working Hard or Hardly Working? Regulatory Bottlenecks in Developing a COVID-19 Vaccine. Extract
  • GET 2020. Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers. Extract
  • GET 2020. Allocation criteria for an initial shortage of a future SARS-CoV-2 vaccine and necessary measures for global immunity. Extract
  • GET 2020. Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality. Extract
  • GET 2020. Emerging manufacturers engagements in the COVID -19 vaccine research, development and supply. Extract
  • GET 2020. Potential for elimination of SAR-CoV-2 through vaccination as inspired by elimination of multiple influenza viruses through natural pandemics or mass vaccination. Extract
  • GET 2020. SARS-CoV-2 vaccination-A plea for fast and coordinated action. Extract
  • GET 2020. Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogens. Extract
  • GET 2020. Are Genetic Vaccines the Right Weapon against COVID-19? Extract
GET 2020. Vaccines against Coronaviruses: The State of the Art. Extract
GET 2020. The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines. Extract
GET 2020. Vaccination against coronaviruses in domestic animals. Extract
  • GET 2020. COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies? Extract
  • GET 2020. An insight into the epitope-based peptide vaccine design strategy and studies against COVID-19. Extract
  • GET 2020. Immunoinformatics study to search epitopes of spike glycoprotein from SARS-CoV-2 as potential vaccine. Extract
Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge